Rosacea;Rosazea

JDDG - Journal of the German Society of Dermatology

Volumn 7, Issue 11, 2009, Pages 996-1003

  Gauwerky, Katharina ^b   Klövekorn, Winfried ^a   Korting, Hans Christian ^a   Lehmann, Percy ^a   Meigel, Eva Maria ^a   Reinel, Dieter ^a   Ruzicka, Thomas ^a   Schaller, Martin ^a   Schöfer, Helmut ^a   Tietze, Julia ^b  

^a Ludwig Maximilian University ^*

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; CLARITHROMYCIN; CLINDAMYCIN; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN; GLUCOCORTICOID; HYDROCORTISONE; ISOTRETINOIN; KETOCONAZOLE; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; PERMETHRIN; PIMECROLIMUS; PLACEBO; PREDNISOLONE; SPIRONOLACTONE; TACROLIMUS; TETRACYCLINE;

CLINICAL FEATURE; DEMODEX; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; GRAM NEGATIVE ROSACEA; GRANULOMATOSIS; GRANULOMATOUS ROSACEA; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MORBIHAN DISEASE; NONHUMAN; OCULAR ROSACEA; PAPULOPUSTULAR ROSACEA; PATHOGENESIS; PHOTODYNAMIC THERAPY; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; ROSACEA; ROSACEA CONGLOBATA; ROSACEA DIATHESIS; ROSACEA ERYTHEMATOSATELANGIECTATICA; ROSACEA FULMINANS; ROSACEA PAPULOPUSTULOSA; SKIN SURGERY; SYSTEMIC THERAPY;

DERMATOLOGY; GERMANY; HUMANS; PRACTICE GUIDELINES AS TOPIC; ROSACEA;

EID: 70350490791     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07119.x     Document Type: Review

References (87)

1. Aizawa H, Niimura M. Oral spironolactone therapy in male patients with rosacea. J Dermatol 1992 19 : 293 297.
2. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology 1997 104 : 1863 1867.
3. Aloi F, Tomasini C, Soro E, Pippione M. The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol 2000 42 : 468 472.
4. Altinyazar HC, Koca R, Tekin NS, Esturk E. Adapalene vs. metronidazole gel for the treatment of rosacea. Int J Dermatol 2005 44 : 252 255.
5. Aroni K, Tsagroni E, Lazaris AC, Patsouris E, Agapitos E. Rosacea: A Clinicopathological Approach. Dermatology 2004 209 : 177 182.
6. Bahmer F, Drosner M, Hohenleutner U, Kaufmann R, Kautz G, Kimmig W, Landthaler M, Neumann R, Raulin C, Seeber N. Empfehlung zur Behandlung mit Laser und hochenergetischen Blitzlampen (HBL) in der Dermatologie. JDDG 2007 11 : 1036 1043.
7. Bakar O, Demirçay Z, Gürbüz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol 2004 43 : 151 154.
8. Baldwin HE. Systemic Therapy for Rosacea. Skin Therapy Lett 2007 12 : 1 5, 9.
9. Bamfordt JTM, Elliot BR, Haller IV. Tacrolimus effect on rosazea. J Am Acad Dermatol 2004 50 : 107 108.
10. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol 1989 69 : 419 423.
11. Berman B, Perez OA, Zell D. Update on rosacea and anti-inflammatory-dose doxycycline. Drugs Today (Barc). 2007 43 : 27 34.
12. Bevins CL, Liu FT. Rosacea: skin innate immunity gone awry? Nat Med 2007 13 : 904 906.
13. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol 1953 65 : 458 463.
14. Brinnel H, Friedel J, Caputa M, Cabanac M, Grosshans E. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res 1989 281 : 66 72.
15. Browning DJ, Proia AD. Ocular rosacea. Surg Ophthalmol 1986 31 : 145 158.
16. Bryld LE, Jemec GB. Photodynamic therapy in a series of rosacea patients. J Eur Acad Dermatol Venereol 2007 21 : 1199 1202.
17. Buechner SA. Rosacea: An Update. Dermatology 2005 210 : 100 108.
18. Chu CY. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Br J Dermatol 2005 : 152 : 396 399.
19. Crawford GH, Pelle MT, James WD. Rosacea. I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004 51 : 327 341.
20. Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 2001 45 : 723 730.
21. Del Rosso JQ, Webster GF, Jackson M, Rendon M, Rich P, Torok H, Bradshaw M. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40 mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 2007 56 : 791 802.
22. Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F. Efficacy of low-dose isotre-tinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998 134 : 884 885.
23. Firooz A, Firoozabadi MR, Dowlati Y. Rosacea fulminans (pyoderma faciale): successful treatment of a 3-year-old girl with oral isotretinoin. Int J Dermatol 2001 40 : 203 205.
24. Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol 1993 128 : 650 659.
25. Fowler JF Jr. Combined effect of antiinflammatory dose doxycycline (40 mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. J Drugs Dermatol 2007 6 : 641 645.
26. Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 2003 22 : 230 233. (Pubitemid 36359159)
27. Gieler U, Niemeier V. Psychologische Aspekte der Rosazea. In : Schöfer H (Hrsg Rosazea. Klinik und aktuelle Therapie. Stuttgart : Georg Thieme Verlag, 2003 : 79 85.
28. Goldberg DJ. Lasers and light sources for rosacea. Cutis 2005 75 : 22 26.
29. Goldman D. Tacrolimus ointment for the treament of steroid-induced rosacea: A preliminary report. J Am Acad Dermatol 2001 : 44 : 995 998.
30. Goon PK, Dalal M, Peart FC. The Gold Standard for Decortication of Rhinophyma: Combined Erbium-YAG/CO2 Laser. Aesthetic Plast Surg 2004 28 : 456 460.
31. Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venerol 2005 19 : 273 285.
32. Helm KF, Menz J, Gibson LE, Dicken CH. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol 1991 25 : 1038 1043.
33. Hölzle E, Jansen T, Plewig G. Morbus Morbihan - Chronisch persistierendes Ödem des Gesichtes. Hautarzt 1995 46 : 796 798.
34. Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol 1986 25 : 660 663.
35. Irvine C, Kumar P, Marks R. Isotretinoin in the treatment of rosacea and rhinophyma. In : Marks R, Plewig G (editors Acne and related disorders: Proceedings of an international symposium. London : Martin Dunitz, 1988 : 301 305.
36. Jansen T, Melnik B, Plewig G. Gram-negative Follikulitis als Begleitkomplikation bei Rosazea. Akt Dermatol 1994 20 : 381 384.
37. Jansen T, Plewig G. Rosacea fulminans. Therapie mit Kortikosteroiden und Isotretinoin. Akt Dermatol 1994 20 : 212 216.
38. Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg 1998 14 : 2412 2453.
39. Jansen T, Regele D, Schirren CG, Trautner B, Plewig G. Persistierendes Erythem und Ödem des Gesichts bei Rosazea und Lymphgefäß dysplasie. Hautarzt 1999 49 : 932 935.
40. Kerscher M, Reuther T. Der Fluch der Kelten - kosmetische Aspekte bei der Rosazea. In : Schöfer H (Hrsg Rosazea. Klinik und aktuelle Therapie. Stuttgart : Georg Thieme Verlag, 2003 : 67 72.
41. Koçak M, Yag̀li S, Vahapoǧlu G, Ekşiog̀ lu M. Permethrin 5% Cream versus Metronidazole Gel for the Treatment of Papulopustular Rosacea. A randomized double-blind placebo-controlled study. Dermatology 2002 205 : 265 270.
42. Koczulla R, von Degenfeld G, Kupatt C, Krötz F, Zahler S, Gloe T, Issbrücker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003 111 : 1665 1672.
43. Korting HC, Schöllmann C. Current topical and systemic approaches to treatment of rosacea EADV, eingereicht.
44. Krause MH, Torricelli R, Kundig T, Trüeb RM, Hafner J. Dapson bei granulomatöser Rosazea. Hautarzt 1997 48 : 246 248.
45. Kroshinsky D, Glick SA. Pediatric rosacea. Dermatol Ther 2006 19 : 196 201.
46. Laube S, Lanigan SW. Laser treatment of rosacea. J Cosmet Dermatol 2002 1 : 188 195.
47. Lehmann P. Rosazea. Klinik, Pathogenese, Therapie. Hautarzt 2005 56 : 871 885.
48. Lehmann P. Rosazea. Dtsch Ärztebl 2007 104 : A 1741, B 1536, C 1475.
49. Leyden JJ, Thew M, Kligman AM. Steroid rosacea. Arch Dermatol 1974 111 : 619 622.
50. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0,75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 1999 40 : 961 965.
51. Maibach H. Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology. Cutis 1991 48 : 411 417.
52. Mainusch, O. Operative Therapie der Rosazea (Rhinophym). In : Schöfer H (Hrsg Rosazea. Klinik und aktuelle Therapie. Stuttgart : Georg Thieme Verlag, 2003 : 73 78.
53. Maisch T, Szeimies RM, Jori G, Abels C. Antibacterial photodynamic therapy in dermatology. Photochem Photobiol Sci 2004 3 : 907 917.
54. Marks R, Ellis J. Comparative effectiveness of tetracycline and ampicillin in rosacea: a controlled trial. Lancet 1971 II : 1049 1052.
55. Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol 1969 100 : 683 691.
56. Marsden JR, Shuster S, Neugebauer M. Response of rosacea to isotretinoin. Clin Exp Dermatol 1984 9 : 484 488.
57. Neumann NJ, Lehmann P. Photodermatosen: Ein Leitfaden zur Diagnostik. Darmstadt, Steinkopff, 2000.
58. Nikolowski J, Plewig G. Rosazea. Orale Behandlung mit 13-cis-Retinsäure. Hautarzt 1980 : 31 : 660 661.
59. Nybaek H, Jemec GB. Photodynamic Therapy in the Treatment of Rosacea. Dermatology 2005 : 211 : 135 138.
60. Oztas MO, Balk M, Ogüs E, Bozkurt M, Ogüs IH, Ozer N. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol 2003 28 : 188 192.
61. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004 51 : 499 512.
62. Petres J. Therapie des Rhinophyms. Hautarzt 1985 36 : 433 435.
63. Plewig G. Akne und Rosazea. In : Braun-Falco O, Plewig G, Wolff H, Burgdorf W, Landthaler M (Hrsg Dermatologie und Venerologie. 5. Auflage. Heidelberg : Springer Verlag, 2005.
64. Plewig G, Jansen T, Kligman AM. Pyoderma faciale. A review and report of 20 additional cases: is it rosacea? Arch Dermatol 1992 128 : 1611 1617.
65. Plewig G, Kligman A. Akne und Rosazea. 2. Auflage, Berlin Heidelberg, Springer Verlag, 1994.
66. Prinz L. Zur Behandlung der Rosacea mit Metronidazol innerlich und äusserlich. Z Hautkr 1984 59 : 181 183.
67. Pye RJ, Burton JL. Treatment of rosacea by metronidazole. Lancet 1976 I : 1211 1212.
68. Rebora A, Drago F, Parodi A. May Helicobacter pylori be important for dermatologists? Dermatology 1995 191 : 6 8.
69. Roihu T, Kariniemi AL. Demodex mites in acne rosacea. J Cutan Pathol 1988 25 : 550 552.
70. Saihan EM, Burton JL. A double-blind trial of metronidazole versus oxytetracycline therapy of rosacea. Br J Dermatol 1980 102 : 443 445.
71. Sanchez J, Somolinos AL, Almodovar PI, Webster G, Bradshaw M, Powala C. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20 mg tablets and metronidazole 0,75% topical lotion in the treatment of rosacea. J Am Acad Dermatol 2005 53 : 791 797.
72. Sapadin AN, Fleischmajer R. Tetracyclines: Nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006 54 : 258 265.
73. Schmidt JB, Raff M. 13-cis Retinsäure: Eine neue Behandlungsform der Rosazea. Wien Klin Wochenschr 1982 94 : 115 118.
74. Schroeter CA, Haaf-von Below S, Neumann HA. Effective Treatment of Rosacea Using Intense Pulsed Light Systems. Dermatol Surg 2005 31 : 1285 1289.
75. Sneddon IB. A clinical trial of tetracycline in rosacea. Br J Dermatol 1966 78 : 649 652.
76. Starr PA. Oculocutaneous aspects of rosacea. Proc R Soc Med 1969 62 : 9 11.
77. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002 16 : 328 333.
78. Torresani C, Pavesi A, Manara GC. Clinical trial on clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol 1997 36 : 938 946.
79. Utas S, Ümit Ü. Treatment of rosacea with ketoconazole. J Eur Acad Dermatol 1997 8 : 69 70.
80. van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S. Systematic review of rosacea treatments. Am Acad Dermatol 2007 56 : 107 115.
81. Vienne MP, Ochando N, Borrel MT, Gall Y, Lauze C, Dupuy P. Retinaldehyde Alleviates Rosacea. Dermatology 1999 199 (suppl 1 53 56.
82. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002 46 : 584 587.
83. Wilkin JK. Effect of subdepressor clonidine of flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol 1983 119 : 211 214.
84. Wilkin JK. Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 1989 20 : 202 205.
85. Wilkin JK, DeWitt S. Treatment of Rosacea. Topical Clindamycin versus oral Tetracyclin. Int J Dermatol 1994 32 : 65 67.
86. Yamamoto Y. Role of active oxygen species and antioxydants in photoaging. J Dermatol Sci 2001 27 (suppl 1 1 4.
87. Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dor-schner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007 13 : 975 980.